Medx Holdings Pursues DEA Registration for Medical Cannabis Operations
Medx Holdings (MEDH) Announces Landmark Submission for DEA Registration Through Lazydaze ABQ LLC, Joining an Elite Group of Public Companies Pioneering Federal Medical Cannabis Access
Image: Benzinga
Medx Holdings, a multi-state cannabis operator based in Austin, Texas, has submitted applications for federal registration with the DEA through its subsidiary Lazydaze ABQ LLC. This move follows the reclassification of medical marijuana to Schedule III, positioning Medx among a select group of public companies advancing federal medical cannabis access.
- 01Medx Holdings submitted its DEA registration application on May 28, 2026, through Lazydaze ABQ LLC.
- 02This submission follows the historic rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
- 03The DEA has introduced a 60-day expedited filing window for qualified state-licensed operators.
- 04Medx aims to integrate regulated medical cannabis products into its recreational cannabis lounges.
- 05The application is expected to significantly expand Medx's market share and customer base.
Advertisement
In-Article Ad
On May 28, 2026, Medx Holdings, a rapidly growing multi-state cannabis operator based in Austin, Texas, announced its submission for federal registration with the U.S. Drug Enforcement Administration (DEA) through its subsidiary, Lazydaze ABQ LLC. This landmark move comes in the wake of the reclassification of medical marijuana to Schedule III under the Controlled Substances Act, which allows for a streamlined application process for state-licensed operators. CEO Hans Enriquez emphasized that this registration will enable Medx to integrate premium, regulated medical cannabis products into its existing recreational lounges, enhancing customer access. The application is seen as a major growth catalyst, allowing Medx to capture new market share and serve a broader patient demographic while maintaining its recreational customer base. Medx Holdings is committed to leading the industry in innovation and compliance, aiming to set a new standard for federally compliant cannabis operations.
Advertisement
In-Article Ad
The DEA registration will enable Medx Holdings to expand its operations and product offerings, benefiting both medical patients and recreational customers.
Advertisement
In-Article Ad
Reader Poll
What do you think about the federal registration of medical cannabis operations?
Connecting to poll...
Read the original article
Visit the source for the complete story.